USPTO serial 79453468
Reviewed by CopyMark Law Group
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of eye diseases and conditions; preparations for ocular or intraocular surgery, agents that facilitate the delivery of pharmaceutical products. | ACTIVE | — |
| 010 | Lamps and irradiation devices for medical purposes; Ultraviolet lamps for medical purposes; lamps for medical purposes with emission in the green light range; lamps, in particular ultraviolet lamps, for treating the eyes; lamps for treating the cornea, in particular for corneal ectasia, infectious keratitis, thinning corneal diseases, sterile melting and for correcting the refraction of human optics. | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 8, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 22, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 22, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 14, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 13, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 13, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 9, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 9, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 2, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |